|Nom||Titre||Payer||Exercé||Année de naissance|
|Mr. Kevin T. Conroy||Chairman, Pres & CEO||1,51M||27,76M||1966|
|Mr. Jeffrey T. Elliott CFA||Chief Financial Officer||643,82k||S.O.||1978|
|Mr. D. Scott Coward||Chief Admin. Officer, Sr. VP, Gen. Counsel & Sec.||745,27k||S.O.||1965|
|Mr. Mark Stenhouse||Pres of Cologuard||952,26k||S.O.||1967|
|Ms. Ana Hooker||Sr. VP of Operations||S.O.||S.O.||1966|
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
L’ISS Governance QualityScore de Exact Sciences Corporation en date du 3 février 2020 est 6. Les scores principaux sont Audit : 1; Société : 6; Droits des actionnaires : 8; Compensation : 7.